{"id":"https://openalex.org/W1488359481","doi":"https://doi.org/10.1212/wnl.82.10_supplement.p3.182","title":"Early and Consistent Reduction in Relapses among Patients with Relapsing-Remitting Multiple Sclerosis Receiving Subcutaneous Interferon Beta-1a: A Post-Hoc Analysis of PRISMS Data (P3.182)","display_name":"Early and Consistent Reduction in Relapses among Patients with Relapsing-Remitting Multiple Sclerosis Receiving Subcutaneous Interferon Beta-1a: A Post-Hoc Analysis of PRISMS Data (P3.182)","publication_year":2014,"publication_date":"2014-04-08","ids":{"openalex":"https://openalex.org/W1488359481","doi":"https://doi.org/10.1212/wnl.82.10_supplement.p3.182","mag":"1488359481"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.82.10_supplement.p3.182","doi":"https://doi.org/10.1212/wnl.82.10_supplement.p3.182","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.82.10_supplement.p3.182","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090198793","display_name":"Mark Cascione","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Cascione","raw_affiliation_strings":["South Tampa Multiple Sclerosis Center Tampa FL United States","3South Tampa Multiple Sclerosis Center Tampa FL United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"South Tampa Multiple Sclerosis Center Tampa FL United States","institution_ids":[]},{"raw_affiliation_string":"3South Tampa Multiple Sclerosis Center Tampa FL United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008219647","display_name":"Carol Gaines","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol Gaines","raw_affiliation_strings":["EMD Serono, Inc. Rockland MA United States","1EMD Serono, Inc. Rockland MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono, Inc. Rockland MA United States","institution_ids":["https://openalex.org/I4210111614"]},{"raw_affiliation_string":"1EMD Serono, Inc. Rockland MA United States","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091507790","display_name":"Juanzhi Fang","orcid":"https://orcid.org/0000-0002-1448-6190","observed_orcids":["https://orcid.org/0000-0002-1448-6190"]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juanzhi Fang","raw_affiliation_strings":["EMD Serono, Inc. Rockland MA United States","1EMD Serono, Inc. Rockland MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono, Inc. Rockland MA United States","institution_ids":["https://openalex.org/I4210111614"]},{"raw_affiliation_string":"1EMD Serono, Inc. Rockland MA United States","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010771032","display_name":"Fernando Dangond","orcid":"https://orcid.org/0000-0002-6723-4229","observed_orcids":["https://orcid.org/0000-0002-6723-4229"]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fernando Dangond","raw_affiliation_strings":["EMD Serono, Inc. Rockland MA United States","1EMD Serono, Inc. Rockland MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono, Inc. Rockland MA United States","institution_ids":["https://openalex.org/I4210111614"]},{"raw_affiliation_string":"1EMD Serono, Inc. Rockland MA United States","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108100040","display_name":"Aaron Miller","orcid":"https://orcid.org/0000-0001-8324-7356","observed_orcids":["https://orcid.org/0000-0001-8324-7356"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Miller","raw_affiliation_strings":["Icahn School of Medicine at Mount Sinai New York NY United States","2Icahn School of Medicine at Mount Sinai New York NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Icahn School of Medicine at Mount Sinai New York NY United States","institution_ids":["https://openalex.org/I98704320"]},{"raw_affiliation_string":"2Icahn School of Medicine at Mount Sinai New York NY United States","institution_ids":["https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.05524924,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"10_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.9589999914169312},{"id":"https://openalex.org/keywords/interferon-beta-1a","display_name":"interferon beta-1a","score":0.968999981880188},{"id":"https://openalex.org/keywords/subcutaneous-interferon-therapy","display_name":"subcutaneous interferon therapy","score":0.871999979019165},{"id":"https://openalex.org/keywords/relapse-rate","display_name":"relapse rate","score":0.8349999785423279},{"id":"https://openalex.org/keywords/early-treatment-response","display_name":"early treatment response","score":0.5640000104904175},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.621999979019165},{"id":"https://openalex.org/keywords/expanded-disability-status-scale","display_name":"Expanded Disability Status Scale","score":0.8619999885559082},{"id":"https://openalex.org/keywords/disability-progression","display_name":"disability progression","score":0.4950000047683716},{"id":"https://openalex.org/keywords/relapse-definition","display_name":"relapse definition","score":0.32600000500679016}],"concepts":[{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.8548104763031006},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7695920467376709},{"id":"https://openalex.org/C2908698914","wikidata":"https://www.wikidata.org/wiki/Q2450337","display_name":"Interferon beta-1a","level":4,"score":0.7059713006019592},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.6955349445343018},{"id":"https://openalex.org/C3020694758","wikidata":"https://www.wikidata.org/wiki/Q42417392","display_name":"Relapsing remitting","level":3,"score":0.6221224069595337},{"id":"https://openalex.org/C2994247566","wikidata":"https://www.wikidata.org/wiki/Q2450337","display_name":"Interferon beta","level":3,"score":0.5282494425773621},{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.5273916125297546},{"id":"https://openalex.org/C2992886853","wikidata":"https://www.wikidata.org/wiki/Q18381816","display_name":"Post hoc","level":2,"score":0.49167972803115845},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4832761883735657},{"id":"https://openalex.org/C2779915905","wikidata":"https://www.wikidata.org/wiki/Q651270","display_name":"Letter to the editor","level":2,"score":0.41845694184303284},{"id":"https://openalex.org/C2910198813","wikidata":"https://www.wikidata.org/wiki/Q1851162","display_name":"Interferon beta-1b","level":4,"score":0.4110146164894104},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1883191466331482},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.82.10_supplement.p3.182","doi":"https://doi.org/10.1212/wnl.82.10_supplement.p3.182","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.82.10_supplement.p3.182","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4297966720","https://openalex.org/W4235963967","https://openalex.org/W2163670346","https://openalex.org/W2169098250","https://openalex.org/W2187513787","https://openalex.org/W2148814846","https://openalex.org/W2044059674","https://openalex.org/W2117941451","https://openalex.org/W2154045653","https://openalex.org/W4251342541"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Compare":[1],"relapse":[2,28,88],"rates":[3],"between":[4],"patients":[5,154,239],"with":[6,52,61,139,242,268],"relapsing-remitting":[7],"multiple":[8],"sclerosis":[9],"(RRMS)":[10],"receiving":[11],"interferon":[12],"(IFN)":[13],"beta-1a":[14,73,169,205,263],"subcutaneously":[15],"(SC)":[16],"or":[17,38,76,79,92,103,117],"placebo":[18,80,179,216,225,246,284],"at":[19],"different":[20],"points":[21],"over":[22,35,42,58,123,181,192,226,248,273,285],"1":[23,36,286],"year.":[24,287],"BACKGROUND:":[25],"As":[26],"RRMS":[27,53],"frequency":[29],"varies,":[30],"trials":[31],"often":[32],"evaluate":[33],"treatments":[34],"year":[37],"longer;":[39],"demonstrating":[40],"effect":[41],"shorter":[43],"periods":[44],"may":[45],"help":[46],"further":[47],"characterize":[48],"efficacy.":[49],"DESIGN/METHODS:":[50],"Adults":[51],"having":[54],"had":[55],"\u88052":[56],"relapses":[57,122,177,214,223,282],"2":[59,82],"years,":[60],"Expanded":[62],"Disability":[63],"Status":[64],"Scale":[65],"score":[66],"0-5.0,":[67],"were":[68,130,155,240],"randomized":[69],"to":[70,96,279],"thrice-weekly":[71],"IFN":[72,168,204,262],"SC":[74,170,206,264],"44":[75,171,207,243],"22":[77],"mcg":[78,172,208,244],"for":[81,137,161],"years":[83],"(PRISMS,":[84],"Lancet":[85],"1998;352:1498-504).":[86],"A":[87],"was":[89,266],"a":[90],"new":[91,100],"worsening":[93],"symptom":[94],"attributable":[95],"MS":[97],"(with":[98],"appropriate":[99],"neurological":[101,105],"abnormality":[102],"focal":[104],"dysfunction)":[106],"lasting":[107],"\u880524":[108],"hours":[109],"without":[110],"fever,":[111],"preceded":[112],"by":[113],"\u880530":[114],"days":[115],"stability":[116],"improvement.":[118],"Between-treatment":[119],"differences":[120,149],"in":[121,150],"3,":[124],"6,":[125,227],"9":[126,202,228],"and":[127,189,201,211,229],"12":[128,230,249],"months":[129,183,194,231,250,275],"assessed":[131,156],"post-hoc":[132],"via":[133,157],"log-linear":[134],"model":[135,159],"adjusting":[136,160],"center":[138],"log":[140],"of":[141,152,271,299],"time":[142],"on":[143],"study":[144],"as":[145,254],"offset":[146],"term;":[147],"between-treatment":[148],"percentages":[151],"relapse-free":[153,241,259],"logistic":[158],"center.":[162],"RESULTS:":[163],"Despite":[164],"4-8":[165],"weeks":[166],"up-titration,":[167],"(n=184)":[173],"yielded":[174,209],"30%":[175],"fewer":[176,191,213,281],"vs.":[178,186,196,215,224,245,283],"(n=187)":[180],"0-3":[182,274],"(mean,":[184],"0.30":[185],"0.43;":[187],"p=0.042)":[188],"39%":[190,210,280],"0-12":[193],"(0.92":[195],"1.51;":[197],"p<0.0001).":[198],"Over":[199,233],"6":[200],"months,":[203,235],"38%":[212],"(p<0.001).":[217],"The":[218],"22-mcg":[219],"dose":[220],"(n=189)":[221],"reduced":[222],"(p<0.01).":[232],"3":[234],"1.18":[236],"times":[237],"more":[238,251],"(p=0.023);":[247],"than":[252],"twice":[253],"many":[255],"(ratio:":[256],"2.02)":[257],"remained":[258],"(p<0.0001).":[260],"CONCLUSIONS:":[261],"therapy":[265],"associated":[267],"rapid":[269],"onset":[270],"action":[272],"despite":[276],"titration,":[277],"improving":[278],"Study":[288],"Supported":[289],"by:":[290],"EMD":[291],"Serono,":[292],"Inc.,":[293],"Rockland,":[294],"MA,":[295],"USA":[296],"(a":[297],"subsidiary":[298],"Merck":[300],"KGaA,":[301],"Darmstadt,":[302],"Germany).":[303]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}